Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RLIC for Atherosclerotic Cerebral Occlusive Disease
NCT04470492Unknown
- Start
- Sep 2020
- Primary completion
- Aug 2022
01
Overview
Randomised, open-label trial in cerebral atherosclerosis, Transient Ischemic Attack (TIA) and ischemic stroke (2 arms). Primary endpoint: 3-month composite cardio-cerebral vascular event rate. Status: unknown.
02
Conditions
cerebral atherosclerosisTransient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT04470492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470492.